Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target trial
Novo Nordisk A/S
David Russell-Jones; Tetsuya Babazono; Roman Cailleteau; Susanne Engberg; Concetta Irace; Maiken Ina Siegismund Kjaersgaard; Chantal Mathieu; Julio Rosenstock; Vincent Woo; David C Klonoff